bay h 4502 and Foot Dermatoses

bay h 4502 has been researched along with Foot Dermatoses in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19903 (27.27)18.7374
1990's3 (27.27)18.2507
2000's2 (18.18)29.6817
2010's3 (27.27)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sarkany, M; Schaller, M; Sigurgeirsson, B1
Baran, R; Bulai-Livideanu, C; Coubetergues, H; Lahfa, M; Ortonne, JP; Paul, C; Piraccini, BM; Richert, B; Sibaud, V; Szepietowski, JC; Tosti, A; Voisard, JJ1
Aspiroz, C; Fortuño-Cebamanos, B; Gilaberte, Y; Rezusta, A1
Baran, R; Tosti, A1
Sellart-Altisent, M; Torres-Rodríguez, JM1
Bonifaz, A; Garcia, C; Guzmán, A; Saúl, A; Sosa, J1
Bergman, R; Bitterman, O; Cohen, A; Friedman-Birnbaum, R; Shemer, A; Stettendorf, S1
Fritsch, H; Hegemann, L; Stettendorf, S1
Nolting, S1
Doherty, VR; Hay, RJ; Midgley, G; Richardson, MD; Roberts, DT1
Allenby, L; Earl, D; Richards, H; Wright, CM1

Trials

5 trial(s) available for bay h 4502 and Foot Dermatoses

ArticleYear
Patient-reported outcomes from two randomised studies comparing once-weekly application of amorolfine 5% nail lacquer to other methods of topical treatment in distal and lateral subungual onychomycosis.
    Mycoses, 2017, Volume: 60, Issue:12

    Topics: Administration, Topical; Adult; Aged; Antifungal Agents; Ciclopirox; Drug Administration Schedule; Female; Foot Dermatoses; Humans; Imidazoles; Lacquer; Male; Medication Adherence; Middle Aged; Morpholines; Onychomycosis; Patient Reported Outcome Measures; Pyridones

2017
Efficacy, safety and tolerability of an optimized avulsion technique with onyster® (40% urea ointment with plastic dressing) ointment compared to bifonazole-urea ointment for removal of the clinically infected nail in toenail onychomycosis: a randomized e
    Dermatology (Basel, Switzerland), 2013, Volume: 226, Issue:1

    Topics: Administration, Topical; Adult; Aged; Antifungal Agents; Female; Foot Dermatoses; Humans; Imidazoles; Male; Middle Aged; Ointments; Onychomycosis; Plastics; Treatment Outcome; Urea

2013
Efficacy and safety of bifonazole urea in the two-phase treatment of onychomycosis.
    International journal of dermatology, 1995, Volume: 34, Issue:7

    Topics: Administration, Topical; Adolescent; Adult; Aged; Antifungal Agents; Child; Child, Preschool; Combined Modality Therapy; Drug Administration Schedule; Female; Foot Dermatoses; Hand Dermatoses; Humans; Imidazoles; Male; Middle Aged; Onychomycosis; Prospective Studies; Treatment Outcome

1995
Treatment of onychomycosis: a randomized, double-blind comparison study with topical bifonazole-urea ointment alone and in combination with short-duration oral griseofulvin.
    International journal of dermatology, 1997, Volume: 36, Issue:1

    Topics: Administration, Oral; Administration, Topical; Adolescent; Adult; Aged; Antifungal Agents; Double-Blind Method; Female; Foot Dermatoses; Griseofulvin; Hand Dermatoses; Humans; Imidazoles; Male; Middle Aged; Onychomycosis; Urea

1997
The topical treatment of onychomycosis using a new combined urea/imidazole preparation.
    Clinical and experimental dermatology, 1988, Volume: 13, Issue:3

    Topics: Administration, Topical; Adult; Aged; Antifungal Agents; Clinical Trials as Topic; Drug Combinations; Female; Foot Dermatoses; Hand Dermatoses; Humans; Imidazoles; Male; Middle Aged; Onychomycosis; Urea

1988

Other Studies

6 other study(ies) available for bay h 4502 and Foot Dermatoses

ArticleYear
Photodynamic therapy with methyl-aminolevulinate can be useful in the management of Scytalidium infections.
    Actas dermo-sifiliograficas, 2013, Volume: 104, Issue:8

    Topics: Aminolevulinic Acid; Antifungal Agents; Aspergillosis; Coinfection; Combined Modality Therapy; Female; Foot Dermatoses; Humans; Imidazoles; Middle Aged; Mitosporic Fungi; Onychomycosis; Photochemotherapy; Photosensitizing Agents

2013
Chemical avulsion with urea nail lacquer.
    The Journal of dermatological treatment, 2002, Volume: 13, Issue:4

    Topics: Administration, Cutaneous; Adult; Aged; Antifungal Agents; Cohort Studies; Female; Foot Dermatoses; Humans; Imidazoles; Lacquer; Male; Middle Aged; Onychomycosis; Urea; Young Adult

2002
[Bilateral proximal cellulitis and onychomycosis in both big toes due to Fusarium solani].
    Revista iberoamericana de micologia, 2006, Volume: 23, Issue:4

    Topics: Antifungal Agents; Cellulitis; Ciclopirox; Diabetes Mellitus, Type 2; Disease Susceptibility; Drug Resistance, Multiple, Fungal; Foot Dermatoses; Fusarium; Humans; Imidazoles; Immunocompetence; Itraconazole; Male; Middle Aged; Mozambique; Onychomycosis; Pyridones; Pyrimidines; Recurrence; Toes; Travel; Triazoles; Urea; Voriconazole

2006
Ultrastructural changes in onychomycosis during the treatment with bifonazole/urea ointment.
    Dermatology (Basel, Switzerland), 1992, Volume: 185, Issue:1

    Topics: Administration, Topical; Antifungal Agents; Drug Combinations; Foot Dermatoses; Humans; Imidazoles; In Vitro Techniques; Microscopy, Electron, Scanning; Nails; Ointments; Onychomycosis; Urea

1992
[Onychomycoses and their successful therapy].
    Wiener medizinische Wochenschrift (1946), 1989, Aug-31, Volume: 139, Issue:15-16

    Topics: Administration, Topical; Antifungal Agents; Drug Therapy, Combination; Foot Dermatoses; Hand Dermatoses; Humans; Imidazoles; Onychomycosis; Urea

1989
Bifonazole 1% gel in the treatment of superficial dermatophytoses and erythrasma of the feet and groin.
    Pharmatherapeutica, 1986, Volume: 4, Issue:8

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Child; Corynebacterium Infections; Dermatomycoses; Erythrasma; Female; Foot Dermatoses; Gels; Groin; Humans; Imidazoles; Male; Middle Aged; Tinea

1986